Entering text into the input field will update the search result below

FDA restricts COVID-19 antibody therapies from Regeneron and Eli Lilly (updated)

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

  • The FDA has restricted the use COVID-19 monoclonal antibody therapies developed by Regeneron (REGN -3.0%) and Eli Lilly (LLY -3.8%) citing their lack of efficacy against the Omicron variant.
  • The impacted therapies are Lilly's

Recommended For You

Related Stocks

SymbolLast Price% Chg
LLY
--
REGN
--